Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.

Tcg Crossover Fund Ii Lp investment portfolio

Tcg Crossover Fund Ii Lp has made numerous investments in companies such as Beacon Therapeutics Holdings, Pheon Therapeutics, and Vicebio within the Healthcare & Life Sciences sector.

vc
Portfolio
3
Team
0

Portfolio (3)

CompanySectorCitySourceLast confirmed on
Beacon Therapeutics Holdings Limited
Beacon Therapeutics Holdings Limited develops and advances gene‑therapy treatments for retinal diseases that cause blindness, including its lead clinical asset laru‑zova (AGTC‑501) for X‑linked retinitis pigmentosa. The company’s focus is on delivering ophthalmic gene‑therapy products for patients with rare and prevalent retinal disorders.
Healthcare & Life SciencesLondonConfirmed2025-08-17
Pheon Therapeutics Ltd
Pheon Therapeutics develops next‑generation antibody‑drug conjugates (ADCs) as targeted therapies for hard‑to‑treat cancers.
Healthcare & Life SciencesSandwichConfirmed2025-10-19

Sign up to see the full portfolio

+1 more company

Sign up

Shareholding changes (3)

Tcg Crossover Fund Ii Lp's positions across portfolio companies
2025

Sign up free to see when this investor has bought or sold shares.

+1 more change

Sign up